Steerable Guide Catheter

K172394 · Abbott Vascular · DRA · Sep 6, 2017 · Cardiovascular

Device Facts

• Record ID: K172394
• Device Name: Steerable Guide Catheter
• Applicant: Abbott Vascular
• Product Code: DRA · Cardiovascular
• Decision Date: Sep 6, 2017
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 870.1280
• Device Class: Class 2

Intended Use

The Steerable Guide Catheter is used for introducing various cardiovascular catheters into the left side of the heart through the interatrial septum.

Device Story

Steerable Guide Catheter system comprises guide catheter, dilator, handle with steering knob, hemostasis valve, and radiopaque distal tip. Used by physicians to introduce cardiovascular catheters into left heart via interatrial septum. Guide catheter allows fluid infusion, aspiration, and conduit for ancillary devices (max diameter 0.204"). Dilator accepts ancillary devices (max diameter 0.035"). Radiopaque tip allows fluoroscopic visualization. Subject device features modified internal tip ring design/processing. Device is single-use, EtO sterilized.

Clinical Evidence

Bench testing only. Tensile strength evaluation compared modified subject device to unmodified predicate. Process validation performed to ensure manufacturing consistency.

Technological Characteristics

Steerable catheter with handle-actuated steering. Components: guide catheter, dilator, radiopaque tip ring, hemostasis valve. Materials: radiopaque elements for fluoroscopy, echogenic tip feature on dilator. Sterilization: EtO. Single-use. Mechanical steering mechanism.

Indications for Use

Indicated for patients requiring introduction of cardiovascular catheters into the left side of the heart via the interatrial septum.

Regulatory Classification

Identification

A steerable catheter is a catheter used for diagnostic and monitoring purposes whose movements are directed by a steering control unit.

Predicate Devices

• Steerable Guide Catheter (K083793)
• Steerable Guide Catheter (K091596)
• Steerable Guide Catheter (K093866)
• Steerable Guide Catheter (K100789)
• Steerable Guide Catheter (K112239)
• Steerable Guide Catheter (K161985)

Submission Summary (Full Text)

{0}------------------------------------------------

# 510(k) Summary

The 510(k) Summary is submitted in accordance with 21 CFR §807.92(c) and the requirements of the Safe Medical Device Act (SMDA) of 1990.

| 1. | Submitter's Name | Abbott Vascular |
|-----|----------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2. | Submitter's Address | 3200 Lakeside Drive Santa Clara, CA 95054 |
| 3. | Telephone | [phone] |
| 4. | Fax | [phone] |
| 5. | Contact Person | Makena Mc Gowan |
| 6. | Date Prepared | August 7, 2017 |
| 7. | Device Trade Name | Steerable Guide Catheter |
| 8. | Device Common Name | Steerable Catheter |
| 9. | Device Classification Name | Catheter, Steerable |
| 10. | Predicate Device Name | K083793 Steerable Guide Catheter<br>K091596 Steerable Guide Catheter<br>K093866 Steerable Guide Catheter<br>K100789 Steerable Guide Catheter<br>K112239 Steerable Guide Catheter<br>K161985 Steerable Guide Catheter |

# 11. Device Description

The Steerable Guide Catheter consists of a Guide and a Dilator provided EtO sterile and for single use only. The Steerable Guide Catheter consists of a distal and proximal catheter shaft, a radiopaque tip ring, a handle with a steering knob, a hemostasis valve with a luer lock flush port, an atraumatic distal tip, and a Dilator with a single central lumen. The central lumen of the Guide allows for aspiration of air and infusion of fluids such as saline, and serves as a conduit during introduction and or exchange of the Dilator and ancillary devices (e.g. catheters) that have a maximum diameter of .204". The atraumatic distal tip of the Steerable Guide Catheter is radiopaque to allow visualization under fluoroscopy. The Dilator consists of a radiopaque shaft, an echogenic feature at the distal tip, a hemostasis valve with a flush port and an internal lumen designed to accept ancillary devices that have a maximum diameter of 0.035" (e.g. needles or guidewires). The Steerable Guide Catheter, Dilator and accessories are packaged in a tray that is individually pouched in a Tyvek/Nylon corner peel pouch, heat-sealed one time, and the single sealed pouch is placed into a cardboard nest and top-loading box.

The subject 510(k) pertains to a design change to the Steerable Guide Catheter. The proposed change to the Steerable Guide Catheter consists of a design and processing modification to the internal feature of the tip ring component at the distal tip.

{1}------------------------------------------------

#### 12. Indication for Use

The Steerable Guide Catheter is used for introducing various cardiovascular catheters into the left side of the heart through the interatrial septum.

### 13. Technological Characteristics

Comparison of the new device and predicate device demonstrate that the technological characteristics such as the fundamental scientific technology, material, and indications for use are substantially equivalent to the current marketed predicate device.

#### 14. Performance Data

Tensile strength evaluation of the catheter tip was conducted on predicate (unmodified) and subject (modified tip) devices to demonstrate that the subject device meets performance specifications and is substantially equivalent to the predicate Steerable Guide Catheter.

Process validation was conducted to demonstrate that the manufacturing process consistently produces subject devices that meet performance specifications.

#### 15. Conclusions

The Steerable Guide Catheter has the same indications for use and performs as well as the predicate device.

{2}------------------------------------------------

# Please wait...

If this message is not eventually replaced by the proper contents of the document, your PDF viewer may not be able to display this type of document.

You can upgrade to the latest version of Adobe Reader for Windows®, Mac, or Linux® by visiting http://www.adobe.com/go/reader_download.

For more assistance with Adobe Reader visit http://www.adobe.com/go/acrreader.

Windows is either a registered trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc., registered in the United States and other countries. Linux is the registered trademark of Linus Torvalds in the U.S. and other countries.

{3}------------------------------------------------

Public Health Service

Image /page/3/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three stylized human profiles facing to the right.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

Abbott Vascular Makena Mc Gowan Regulatory Affairs Specialist 3200 Lakeside Drive Santa Clara, California 95054

Re: K172394

Trade/Device Name: Steerable Guide Catheter Regulation Number: 21 CFR 870.1280 Regulation Name: Steerable Catheter Regulatory Class: Class II Product Code: DRA Dated: August 7, 2017 Received: August 8, 2017

Dear Ms. Mc Gowan:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device

{4}------------------------------------------------

related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure